Search

Author/Creator Massoud, Tarik

1. BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA. (25th March 2021)

Authors:
Beinat, Corinne; Patel, Chirag; Haywood, Tom; Murty, Surya; Naya, Lewis; Hayden-Gephart, Melanie; Khalighi, Mehdi; Massoud, Tarik; Iagaru, Andrei; Davidzon, Guido; Thomas, Reena; Nagpal, Seema; Recht, Lawrence; Gambhir, Sanjiv
Journal:
Neuro-oncology advances
Issue:
Volume 3(2021)Supplement 1
Page Start:
i3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DDIS-16. A MOLECULAR IMAGING BIOSENSOR MONITORS THE EFFECTS OF ANTI-MISFOLDING DRUGS THAT RESTORE MUTANT p53 FUNCTION AND ENHANCE COMBINATION CHEMOTHERAPY FOR GLIOBLASTOMA. Issue 11 (6th November 2017)

Authors:
Paulmurugan, Ramasamy; Afjei, Rayhaneh; Babikir, Husam; Sekar, Thillai; Massoud, Tarik
Journal:
Neuro-oncology
Issue:
Volume 19:Issue 11(2017)supplement 6
Page Start:
vi62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. EXTH-28. TARGETED POLYGIONS ENGINEERED WITH SURFACE miRNAs FOR COMBINED MULTIMODALITY IMAGING AND ENHANCEMENT OF TEMOZOLOMIDE TREATMENT: A NOVEL INTRANASALLY-DELIVERED THERANOSTIC STRATEGY AGAINST GLIOBLASTOMA. (11th November 2019)

Authors:
Sukumar, Uday; Afjei, Rayhaneh; Massoud, Tarik; Paulmurugan, Ramasamy
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗